Use of EGFR biomarkers for the treatment of gastric cancer with anti-EGFR drugs

摘要

The present invention relates to a method for treating gastric tumors, and in particular to a method for treating a patient previously determined to have an EGFR biomarker. Gastric carcinoma (GC) is one of the most common and fatal cancers with a high incidence in East Asia, with approximately 1 million diagnoses and 700,000 deaths annually worldwide.